JP2019517590A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019517590A5 JP2019517590A5 JP2019516293A JP2019516293A JP2019517590A5 JP 2019517590 A5 JP2019517590 A5 JP 2019517590A5 JP 2019516293 A JP2019516293 A JP 2019516293A JP 2019516293 A JP2019516293 A JP 2019516293A JP 2019517590 A5 JP2019517590 A5 JP 2019517590A5
- Authority
- JP
- Japan
- Prior art keywords
- active agent
- composition
- condition
- porous
- excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022067716A JP7571078B2 (ja) | 2016-06-03 | 2022-04-15 | 多孔性賦形剤を含む経鼻用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662345369P | 2016-06-03 | 2016-06-03 | |
| US62/345,369 | 2016-06-03 | ||
| PCT/IB2017/053288 WO2017208209A1 (en) | 2016-06-03 | 2017-06-02 | Nasal pharmaceutical compositions with a porous excipient |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022067716A Division JP7571078B2 (ja) | 2016-06-03 | 2022-04-15 | 多孔性賦形剤を含む経鼻用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019517590A JP2019517590A (ja) | 2019-06-24 |
| JP2019517590A5 true JP2019517590A5 (https=) | 2020-07-16 |
| JP7542309B2 JP7542309B2 (ja) | 2024-08-30 |
Family
ID=59078127
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019516293A Active JP7542309B2 (ja) | 2016-06-03 | 2017-06-02 | 多孔性賦形剤を含む経鼻用医薬組成物 |
| JP2022067716A Active JP7571078B2 (ja) | 2016-06-03 | 2022-04-15 | 多孔性賦形剤を含む経鼻用医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022067716A Active JP7571078B2 (ja) | 2016-06-03 | 2022-04-15 | 多孔性賦形剤を含む経鼻用医薬組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11903951B2 (https=) |
| EP (1) | EP3463375A1 (https=) |
| JP (2) | JP7542309B2 (https=) |
| KR (1) | KR102387241B1 (https=) |
| CN (1) | CN109803663A (https=) |
| AU (1) | AU2017274649B2 (https=) |
| EA (1) | EA201892595A1 (https=) |
| MX (1) | MX389588B (https=) |
| SG (1) | SG11201810628XA (https=) |
| WO (1) | WO2017208209A1 (https=) |
| ZA (1) | ZA201808551B (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110461340A (zh) | 2017-01-20 | 2019-11-15 | 马特恩制药股份公司 | 用于降低暴露于空气污染物的风险的鼻用药物组合物 |
| RU2020126425A (ru) | 2018-01-11 | 2022-02-11 | М Эт П Фарма Аг | Лечение демиелинизирующих заболеваний |
| CN110545794B (zh) * | 2018-01-22 | 2021-02-26 | 北京茵诺医药科技有限公司 | 用于靶向活化cd44分子的胶束纳米载体递送系统、其制备方法和用途 |
| WO2019202504A1 (en) | 2018-04-17 | 2019-10-24 | M et P Pharma AG | Compositions and methods for intranasal delivery of pregnenolone |
| EP3837266A1 (en) | 2018-08-17 | 2021-06-23 | Massachusetts Institute of Technology | Degradable polymers of a cyclic silyl ether and uses thereof |
| EP4058501A1 (en) | 2019-11-15 | 2022-09-21 | Massachusetts Institute of Technology | Functional oligomers and functional polymers including hydroxylated polymers and conjugates thereof and uses thereof |
| JP2023504876A (ja) * | 2019-12-06 | 2023-02-07 | シャンハイ ファーマシューティカルズ ホールディング カンパニー，リミティド | 薬物組成物、キット及びその応用 |
| RS63725B1 (sr) | 2020-05-18 | 2022-12-30 | Orexo Ab | Nova farmaceutska kompozicija za davanje leka |
| JP2021000483A (ja) * | 2020-09-15 | 2021-01-07 | 株式会社三洋物産 | 遊技機 |
| JP2021000484A (ja) * | 2020-09-15 | 2021-01-07 | 株式会社三洋物産 | 遊技機 |
| JP2021000481A (ja) * | 2020-09-15 | 2021-01-07 | 株式会社三洋物産 | 遊技機 |
| CN112263546B (zh) * | 2020-09-29 | 2021-08-10 | 南京大学 | 通过鼻腔给药的佐匹克隆混悬液纳米制剂及其制备方法 |
| CN117062852A (zh) | 2021-02-01 | 2023-11-14 | 麻省理工学院 | 可再加工的组合物 |
| CN112972428B (zh) * | 2021-03-09 | 2022-03-08 | 石河子大学 | 两性离子聚合物膜包覆的介孔硅基药物载体及制备方法 |
| CN113456576B (zh) * | 2021-06-28 | 2022-09-16 | 华中科技大学 | 纳米材料用于制备鼻腔纳米制剂脑靶向递送肠道药物应用 |
| GB202117016D0 (en) | 2021-11-25 | 2022-01-12 | Orexo Ab | New pharmaceutical device |
| AR127780A1 (es) | 2021-11-25 | 2024-02-28 | Orexo Ab | Nueva composición farmacéutica que comprende adrenalina |
| US20230310440A1 (en) * | 2022-04-01 | 2023-10-05 | Enalare Therapeutics Inc. | Respiratory stimulant nasal formulations |
| CN115505052B (zh) * | 2022-08-23 | 2023-05-23 | 安徽普利药业有限公司 | 一种β-环糊精衍生物的制备方法 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5002597A (en) | 1989-04-03 | 1991-03-26 | Invent Ag | Aerodynamic filter |
| US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
| DE19701912C1 (de) * | 1997-01-10 | 1998-05-14 | Jenapharm Gmbh | Injizierbares Implantat |
| DE10064950A1 (de) | 2000-12-23 | 2002-07-11 | Impetus Ag Basel | Thixotropes Nasenspray |
| US7001615B1 (en) | 2001-12-07 | 2006-02-21 | Alcon, Inc. | Sustained release ophthalmic, otic and nasal suspension |
| US7563451B2 (en) * | 2003-07-22 | 2009-07-21 | Iowa State University Research Foundation, Inc. | Capped mesoporous silicates |
| US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
| ATE319426T1 (de) | 2003-11-11 | 2006-03-15 | Mattern Udo | Nasenformulierung mit kontrollierter freisetzung von sexualhormonen |
| US20060140820A1 (en) | 2004-12-28 | 2006-06-29 | Udo Mattern | Use of a container of an inorganic additive containing plastic material |
| WO2007041079A2 (en) * | 2005-09-30 | 2007-04-12 | Alza Corporation | Banded controlled release nanoparticle active agent formulation dosage forms and methods |
| WO2008040488A1 (en) | 2006-10-04 | 2008-04-10 | M & P Patent Aktiengesellschaft | Controlled release delivery system for nasal application of neurotransmitters |
| EP2077754B1 (en) | 2006-10-13 | 2011-03-23 | Koninklijke Philips Electronics N.V. | Switchable joint constraint system |
| US8258137B2 (en) * | 2008-01-29 | 2012-09-04 | Katholieke Universiteit Leuven | Process for release of biologically active species from mesoporous oxide systems |
| CA2778604C (en) * | 2008-09-23 | 2021-10-05 | Laboratory Skin Care, Inc. | Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same |
| US8778401B2 (en) * | 2008-10-28 | 2014-07-15 | Agency For Science, Technology And Research | Mesoporous material excipients for poorly aqueous soluble ingredients |
| US20130040922A1 (en) | 2011-05-13 | 2013-02-14 | Trimel Pharmaceuticals Corporation | Intranasal 0.45% and 0.48% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| ES2825799T3 (es) | 2011-05-13 | 2021-05-17 | Acerus Biopharma Inc | Formulaciones en gel de testosterona intranasal de concentración de dosis más baja y uso de las mismas para tratar anorgasmia o trastorno del deseo sexual hipoactivo |
| KR102568894B1 (ko) * | 2011-05-15 | 2023-08-21 | 에이세러스 바이오파마 인크. | 비내용 테스토스테론 겔의 조절된 방출, 경비성 투여를 위한 방법 및 미리-충전된 다회 용량 도포기 시스템 |
| ITTO20111242A1 (it) * | 2011-12-30 | 2013-07-01 | Miso S R L | Composizioni per il trattamento di patologie delle mucose |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| WO2014076569A2 (en) * | 2012-11-14 | 2014-05-22 | Trimel Biopharma Srl | Controlled release topical testosterone formulations and methods |
| US20150290217A1 (en) * | 2012-11-21 | 2015-10-15 | Trimel Biopharma Srl | Male testosterone titration methods, male intranasal testosterone bio-adhesive gel formulations and use thereof for treating hypogonadism and trt |
| US9474720B2 (en) * | 2013-11-04 | 2016-10-25 | BioPharmX, Inc. | Dosage form comprising an active ingredient and a plurality of solid porous microcarriers |
| EP3193836A1 (en) | 2014-09-15 | 2017-07-26 | PharmaSol GmbH | Active-loaded particulate materials for topical administration |
| EP3331498B1 (en) | 2015-08-04 | 2020-03-11 | WindStar Medical GmbH | A nasal composition |
| WO2017042709A1 (en) | 2015-09-09 | 2017-03-16 | King Abdullah University Of Science And Technology | Functionalized sio2 microspheres for extracting oil from produced water |
| EP3229549B1 (en) * | 2016-04-08 | 2018-11-21 | Panasonic Intellectual Property Corporation of America | Procedures for grouping wearable devices with lte master ues |
| CN110461340A (zh) | 2017-01-20 | 2019-11-15 | 马特恩制药股份公司 | 用于降低暴露于空气污染物的风险的鼻用药物组合物 |
-
2017
- 2017-06-02 EP EP17731299.8A patent/EP3463375A1/en active Pending
- 2017-06-02 CN CN201780047958.8A patent/CN109803663A/zh active Pending
- 2017-06-02 WO PCT/IB2017/053288 patent/WO2017208209A1/en not_active Ceased
- 2017-06-02 JP JP2019516293A patent/JP7542309B2/ja active Active
- 2017-06-02 EA EA201892595A patent/EA201892595A1/ru unknown
- 2017-06-02 US US15/612,454 patent/US11903951B2/en active Active
- 2017-06-02 AU AU2017274649A patent/AU2017274649B2/en active Active
- 2017-06-02 MX MX2018014906A patent/MX389588B/es unknown
- 2017-06-02 SG SG11201810628XA patent/SG11201810628XA/en unknown
- 2017-06-02 KR KR1020197000033A patent/KR102387241B1/ko active Active
-
2018
- 2018-12-19 ZA ZA2018/08551A patent/ZA201808551B/en unknown
-
2022
- 2022-04-15 JP JP2022067716A patent/JP7571078B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019517590A5 (https=) | ||
| JP7571078B2 (ja) | 多孔性賦形剤を含む経鼻用医薬組成物 | |
| JP7366178B2 (ja) | 鼻腔内薬学的粉末組成物 | |
| CN102046153B (zh) | 包含布立西坦的药物组合物 | |
| ES2517244T3 (es) | Forma farmacéutica hinchable que comprende goma gellan | |
| CN101400343B (zh) | 含有药物-离子交换树脂复合物的经修饰释放的制剂 | |
| CN107811980B (zh) | 快速溶解固体剂型 | |
| JP2014506583A5 (https=) | ||
| CN102325526A (zh) | 延长释放的药物制剂 | |
| US20210386858A1 (en) | Mucoadhesive compositions and uses thereof | |
| JP2026062756A (ja) | ガンマ－ヒドロキシ酪酸誘導体の組み合わされた放出製剤の薬物動態 | |
| Domínguez-Delgado et al. | Drug Carrier Systems Using Chitosan for Non Parenteral | |
| CN118829647A (zh) | 白介素-23受体的肽抑制剂及其药物组合物 | |
| CN107205950A (zh) | 金刚烷胺组合物的施用方法 | |
| JP2005508872A5 (https=) | ||
| JP2021517150A (ja) | 圧縮医薬剤形にて使用するための多孔質シリカ粒子 | |
| CN1921888A (zh) | 盐酸坦舒洛新的口服组合物和包含该组合物的控释颗粒制剂 | |
| WO2021108801A2 (en) | Long acting nmda antagonists | |
| Elmowafy et al. | Polysaccharide-based platforms for nasal delivery: design, features, and perspectives | |
| JP2001055323A (ja) | 粉末状経鼻投与用組成物 | |
| KR20140003544A (ko) | 약제학적 제제 | |
| CN105377303A (zh) | 口腔崩解片 | |
| JP2015529196A5 (https=) | ||
| CN107753446B (zh) | 一种雷沙吉兰片剂及其制备方法 | |
| Omidian et al. | Chitosan Nanoparticles for Intranasal Drug Delivery. Pharmaceutics 2024, 16, 746 |